Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).

Chae YK, Chang S, Ko T, Anker J, Agte S, Iams W, Choi WM, Lee K, Cruz M.

Sci Rep. 2018 Feb 13;8(1):2918. doi: 10.1038/s41598-018-21061-1.

2.

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.

Lou Y, Diao L, Cuentas ER, Denning WL, Chen L, Fan YH, Byers LA, Wang J, Papadimitrakopoulou VA, Behrens C, Rodriguez JC, Hwu P, Wistuba II, Heymach JV, Gibbons DL.

Clin Cancer Res. 2016 Jul 15;22(14):3630-42. doi: 10.1158/1078-0432.CCR-15-1434. Epub 2016 Feb 5.

3.

Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.

Mahmood MQ, Ward C, Muller HK, Sohal SS, Walters EH.

Med Oncol. 2017 Mar;34(3):45. doi: 10.1007/s12032-017-0900-y. Epub 2017 Feb 14.

PMID:
28197929
4.

Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.

Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT.

Mol Cancer. 2018 Sep 27;17(1):140. doi: 10.1186/s12943-018-0889-7.

5.

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.

Kinoshita T, Kudo-Saito C, Muramatsu R, Fujita T, Saito M, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Hayashi Y, Kaseda K, Kamiyama I, Ohtsuka T, Tomizawa K, Shimoji M, Mitsudomi T, Asamura H, Kawakami Y.

Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23.

PMID:
28950145
6.

Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer.

Chae YK, Choi WM, Bae WH, Anker J, Davis AA, Agte S, Iams WT, Cruz M, Matsangou M, Giles FJ.

Sci Rep. 2018 Jan 18;8(1):1023. doi: 10.1038/s41598-018-19454-3.

7.

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.

Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X, Ning J, Geng Q, Wang C, Hu Y, Li M, Niu W, Li E, Wu Y.

Oncotarget. 2017 Jun 13;8(24):38825-38840. doi: 10.18632/oncotarget.16404.

8.

MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.

Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A.

Mol Cancer Ther. 2014 Feb;13(2):444-53. doi: 10.1158/1535-7163.MCT-13-0448. Epub 2013 Nov 20.

9.

Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.

Yin H, Wang Y, Chen W, Zhong S, Liu Z, Zhao J.

Gene. 2016 Dec 5;594(1):23-29. doi: 10.1016/j.gene.2016.08.043. Epub 2016 Aug 28.

PMID:
27581786
10.

Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.

Li C, Wan L, Liu Z, Xu G, Wang S, Su Z, Zhang Y, Zhang C, Liu X, Lei Z, Zhang HT.

Cancer Lett. 2018 Apr 1;418:185-195. doi: 10.1016/j.canlet.2018.01.036. Epub 2018 Jan 17.

PMID:
29339211
11.

Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.

Wang L, Yang H, Lei Z, Zhao J, Chen Y, Chen P, Li C, Zeng Y, Liu Z, Liu X, Zhang HT.

Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.

PMID:
25961934
12.

MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.

Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang HT, Zhao J.

Lung Cancer. 2016 Jul;97:87-94. doi: 10.1016/j.lungcan.2016.04.017. Epub 2016 Apr 27.

PMID:
27237033
13.

Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.

Li J, Liu Y, Xue J, Xu M, Zhang J, Liu J, Wang W.

Pathol Oncol Res. 2019 Jan;25(1):115-121. doi: 10.1007/s12253-017-0321-4. Epub 2017 Oct 6.

PMID:
28986741
14.

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.

Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener RA.

BMC Cancer. 2012 Jan 24;12:35. doi: 10.1186/1471-2407-12-35.

15.

FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC.

Kong FF, Zhu YL, Yuan HH, Wang JY, Zhao M, Gong XD, Liu F, Zhang WY, Wang CR, Jiang B.

Oncol Res. 2014;22(1):29-37. doi: 10.3727/096504014X14078436004987.

PMID:
25700356
16.

MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.

Lu C, Shan Z, Hong J, Yang L.

Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.

PMID:
28534966
17.

FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.

He Y, Xie H, Yu P, Jiang S, Wei L.

Cancer Chemother Pharmacol. 2018 Dec;82(6):1049-1059. doi: 10.1007/s00280-018-3697-2. Epub 2018 Oct 9.

PMID:
30302523
18.

Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.

Risolino M, Mandia N, Iavarone F, Dardaei L, Longobardi E, Fernandez S, Talotta F, Bianchi F, Pisati F, Spaggiari L, Harter PN, Mittelbronn M, Schulte D, Incoronato M, Di Fiore PP, Blasi F, Verde P.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3775-84. doi: 10.1073/pnas.1407074111. Epub 2014 Aug 25.

19.

Epithelial Mesenchymal Transition in Aggressive Lung Cancers.

Mittal V.

Adv Exp Med Biol. 2016;890:37-56. doi: 10.1007/978-3-319-24932-2_3. Review.

PMID:
26703798
20.

Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.

Zhang W, Wu X, Hu L, Ma Y, Xiu Z, Huang B, Feng Y, Tang X.

Oncol Res. 2017 May 24;25(5):843-852. doi: 10.3727/096504016X14813880882288. Epub 2016 Dec 15.

PMID:
28508744

Supplemental Content

Support Center